團隊
ホーム >> 専門分野 >> バイオ医薬 >> Katherine Juang
莊郁沁 Katherine Juang

Katherine Juang Katherine Juang

アソシエートパートナー

聯絡方式

Katherine is an associate partner at the firm’s Corporate and Investment Department and is a core member of the Healthcare & Life Sciences practice groups. Katherine has substantial experience in providing comprehensive legal services to clients from the health and life science sector. She has been providing legal consultation on risk management and compliance regarding transactions and interaction with health care providers, regulatory matters, data protection, promotional activities, general code of conduct, and has assisted clients in negotiation and remedy in reimbursement price disputes. She has also represented many multinational pharmaceutical companies in patent litigation, unfair competition claims, IP collaboration and licensing negotiations, and patent term extension disputes. In addition, Katherine also advises on product liability issues, including the pre-marketing and post-marketing legal compliance, product recalls and other product regulatory issues in Taiwan. She has provided long-term consultation services to many multi-national enterprises and international law firms.

學歷

專業領域

Healthcare & Life Sciences; Product Law; Competition Law; Intellectual Property; Dispute Resolution

經歷

Courses Planning Counselor, Graduate Institute of Health and Biotechnology Law, TMU Lecturer, Graduate Institute of Health and Biotechnology Law, TMU Counselor, GMO Food Counselors Commission, Taiwan FDA Board Director, Taiwan Society for Biopreservation and Biobanking

資格

R.O.C. arbitrator (2019) Admitted to Taiwan Bar Association (2002)

語言

2023年 Court rules in favour of pharmaceutical companies that market category two new drugs
ILO IP Newsletter (20230424)
2023年 Taipei High Administrative Court's Latest Ruling: Patent Information of "Category II New Drugs" Allowed to be Submitted in Patent Linkage Registration System
LEXOLOGY
2022年 Taipei High Administrative Court's Latest Ruling: Patent Information of "Category II New Drugs" Allowed to be Submitted in Patent Linkage Registration System
LEXOLOGY
2022年 Constitutional Court Found National Health Insurance Database Lacking Proper Privacy Protection and Ordered Relevant Laws be Amended or New Laws be Promulgated within Three Years
LEXOLOGY
2022年 Constitutional Court Found National Health Insurance Database Lacking Proper Privacy Protection and Ordered Relevant Laws be Amended or New Laws be Promulgated within Three Years
LEXOLOGY
2022年 Medical Devices & Consumer Health Products 2022 – Taiwan
Chambers Global Practice Guides: Medical Devices & Consumer Health Products 2022
2022年 論標語在我國取得商標保護之阻礙──以識別性為中心
月旦法學326期
2021年 Medical Devices & Consumer Health Products 2021 – Taiwan
Chambers Global Practice Guides: Medical Devices & Consumer Health Products 2021

More


回上一頁